|
SAMHD1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.514240E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.441000E-01 |
| Normal-vs-Stage2 |
6.003500E-04 |
| Normal-vs-Stage3 |
2.080200E-01 |
| Normal-vs-Stage4 |
1.979380E-01 |
| Stage1-vs-Stage2 |
2.41769999999031E-05 |
| Stage1-vs-Stage3 |
4.106600E-01 |
| Stage1-vs-Stage4 |
3.663400E-01 |
| Stage2-vs-Stage3 |
5.600100E-03 |
| Stage2-vs-Stage4 |
5.676200E-02 |
| Stage3-vs-Stage4 |
7.970800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.464200E-01 |
| Normal-vs-AfricanAmerican |
1.343800E-01 |
| Normal-vs-Asian |
3.338800E-01 |
| Caucasian-vs-AfricanAmerican |
2.871400E-01 |
| Caucasian-vs-Asian |
6.755400E-01 |
| AfricanAmerican-vs-Asian |
4.410800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.011800E-01 |
| Normal-vs-Female |
1.603360E-01 |
| Male-vs-Female |
8.362000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.094400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.147700E-02 |
| Normal-vs-Age(61-80Yrs) |
5.041700E-02 |
| Normal-vs-Age(81-100Yrs) |
6.365400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.116400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.728100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.266800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.089800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.203400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.422400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.878000E-01 |
| Classical-VS-Follicular |
2.79160028426872E-11 |
| Classical-VS-Other |
2.055200E-01 |
| Classical-VS-Normal |
7.002400E-01 |
| Tall-VS-Follicular |
5.263000E-03 |
| Tall-VS-Other |
2.856600E-01 |
| Tall-VS-Normal |
7.982000E-01 |
| Follicular-VS-Other |
4.990200E-01 |
| Follicular-VS-Normal |
3.84319999999772E-05 |
| Other-VS-Normal |
1.718180E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.441700E-02 |
| Normal-vs-N1 |
1.546370E-01 |
| N0-vs-N1 |
6.704000E-01 |
|
|
